News Focus
News Focus
Followers 6461
Posts 164194
Boards Moderated 5
Alias Born 06/04/2009

Re: PennyHoper post# 23926

Wednesday, 09/03/2025 10:47:26 AM

Wednesday, September 03, 2025 10:47:26 AM

Post# of 25218
WCVC - Trump Confirms Marijuana Rescheduling




__________________________________________________________________


Trump Confirms Marijuana Rescheduling

https://www.jdsupra.com/legalnews/president-trump-confirms-marijuana-7853330/#:~:text=President%20Trump's%20renewed%20focus%20on,financial%20relief%20for%20cannabis%20businesses


Cannabis stocks rally after Trump says he is weighing drug reclassification

https://www.cnbc.com/2025/08/11/cannabis-stocks-trump-considering-reclassification-weed.html


_____________________________________________________________


The administration is reviewing a proposal
to reclassify cannabis
from Schedule I to Schedule III, which would:


Deliver billions in tax relief:
The elimination of IRS Section 280E restrictions
would allow cannabis companies to deduct ordinary business expenses,
improving net margins by double digits
and freeing up billions in reinvestment capital across the sector.

Unlock capital markets:
Banks, lenders, and institutional investors-
previously sidelined due to regulatory risk-
would gain clearance to enter the cannabis space,
fueling an unprecedented wave of financing,
credit, and equity growth.

Elevate cannabis as legitimate medicine:
Federal recognition of marijuana's medical value
would boost physician confidence,
accelerate clinical trials,
and enhance credibility with healthcare providers and patients alike.

Catalyze M&A and consolidation:
Regulatory clarity would supercharge
mergers, acquisitions,
and strategic alliances,
positioning leading companies to seize early-mover advantage.

Ignite investor sentiment:
Cannabis equities have already rallied on rescheduling optimism.
A formal reclassification could spark another surge,
creating generational wealth opportunities for early shareholders.


Investor Highlights

President Trump confirms marijuana rescheduling is under active review.

Federal reform could unleash a $30+ billion U.S. cannabis market opportunity.

IRS 280E tax relief expected to save the industry billions annually.

Expanded access to institutional capital, banking, and financing.

Growing public approval of legalization with nearly 70% of Americans in support.


__________________________________________________________________





Live! Charts








Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now